Antigen levels of CATB, CATL, uPA, PAI-1 and CEA, CA 19-9 levels showed a trend toward higher levels in patients with colon cancer compared to patients with rectal cancer, but the differences were not statistically significant (data not shown). This evidence concerns the gene CEACAM5 and rectal cancer.